Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance
In the News
Comp sector widens scope of recovery efforts
Watch Now
CE Webinar
Specialty is the New Ancillary
On-Demand
CE credit is not available for previously recorded sessions. All You Need to Know About Specialty Networks
Workers' Comp
News Release
September 2022 Utilization Review Compliance Update
As your utilization review (UR) vendor, we want to keep you informed of regulation updates that impact the UR business.
Mitchell
Blog
Examining High-Impact Drug Class Trends
As part of our supplemental podcast series to Mitchell’s Drug Trends Report, we’ve brough back Nik
Workers' Comp
Article
IME: A Tool for Effective Claim Management
In workers’ compensation, all claims are not created equal.
Mitchell
News Release
Mitchell Transforms Estimating Platform to Meet the Needs of Electric Vehicles
Company pioneers new industry advancements that support accurate and efficient collision-damage appraisals of electric vehicles as market prep